APA (7th ed.) Citation

Hortobagyi, G. N., Stemmer, S. M., Burris, H. A., Yap, Y., Sonke, G. S., Hart, L., . . . O'Shaughnessy, J. (2022). Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer. New England Journal of Medicine, 386(10), 942. https://doi.org/10.1056/NEJMoa2114663

Chicago Style (17th ed.) Citation

Hortobagyi, Gabriel N., et al. "Overall Survival with Ribociclib Plus Letrozole in Advanced Breast Cancer." New England Journal of Medicine 386, no. 10 (2022): 942. https://doi.org/10.1056/NEJMoa2114663.

MLA (9th ed.) Citation

Hortobagyi, Gabriel N., et al. "Overall Survival with Ribociclib Plus Letrozole in Advanced Breast Cancer." New England Journal of Medicine, vol. 386, no. 10, 2022, p. 942, https://doi.org/10.1056/NEJMoa2114663.